The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.
Lesinski GB, Anghelina M, Zimmerer J, Bakalakos T, Badgwell B, Parihar R, Hu Y, Becknell B, Abood G, Chaudhury AR, Magro C, Durbin J, Carson WE 3rd.
Lesinski GB, et al.
J Clin Invest. 2003 Jul;112(2):170-80. doi: 10.1172/JCI16603.
J Clin Invest. 2003.
PMID: 12865406
Free PMC article.